WallStreetZenWallStreetZen

How to Buy Resmed Stock

Resmed Inc

Resmed is a medical company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker RMD on the NYSE exchange.

Resmed stock last closed at $224.60, down 0.89% from the previous day, and has decreased 5.24% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.05 percentage points. Resmed stock is currently +18.59% from its 52-week low of $189.40, and -14.4% from its 52-week high of $262.38.

As of Feb 3, 2023, there are 146.91M shares of RMD outstanding. The market cap of RMD is $33.00B. In the last 24 hours, 536,680 RMD shares were traded.

How to Buy Resmed Stock

Wondering how to invest in Resmed stock? Here's how.
  1. Decide where to buy Resmed stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you choose where to buy Resmed stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Deposit funds into your brokerage account: Choose your method of payment and add your details.
  4. Analyze Resmed stock: The Resmed ticker symbol is RMD. Is Resmed stock a good investment? Should you buy shares of RMD? How do RMD's underlying business fundamentals look? Do top analysts think Resmed is a good buy? Why has RMD's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if RMD is a good stock to buy).
  5. Execute your RMD buy order: Decide if you will purchase RMD shares at the current market price or use a limit order to buy RMD stock at a particular price.
  6. Get updates on your RMD investment: Create a watchlist to watch your position in Resmed stock.

Step 1: Decide where to buy Resmed stock

You need a brokerage account in order to access the NYSE market and buy RMD shares.

A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our analysis, eToro is the best brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to world markets: From Technology to Financial Services, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by creating an account with eToro today.

Open eToro Account

Step 2: Open your brokerage account

Now that you've picked your brokerage, it's time to fill out some personal details so you can invest in RMD stock today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
  2. Enter your personal details to create a new brokerage account.
  1. Submit your info by clicking the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your brokerage account

Now that you have filled out your info on stock apps to use, your next step is to transfer the money for your investment:

Check out this video walkthrough to see the process of transferring money into your brokerage account.

Get started with eToro today

Step 4: Analyze Resmed stock

Once you have decided on the best place to buy Resmed stock, it's important to research their stock prior to investing, so you truly understand the risk and opportunity.

Resmed Numbers

RMD Price
$224.60
1w %
0%
1y %
-5.24%
5y %
140.65%
P/E
40.61x
P/B
8.83x
P/S
8.76x
PEG
2.67x
Revenue
$3.76B
Earnings
$809.47M
Fore. Rev. Growth
6.48%
Fore. Earn. Growth
16.92%
Market Cap
$33.00B
Next Earnings
N/A
Next Dividend
Mar 16, 2023

RMD Zen Score

WallStreetZen was built to help part-time investors perform more accurate fundamental analysis in less time.

You can see all of the due diligence checks on RMD's stock page.

How is RMD stock valued?

Analysts use many financial metrics, analyses, models, and charts to gauge RMD's true value.

Using relative valuations measures:

  • RMD may be undervalued based on its P/E ratio of 40.61x, relative to Medical Instruments & Supplies industry P/E ratio of -101.35x
  • RMD may be overvalued based on its P/B ratio of 8.83x, relative to Medical Instruments & Supplies industry P/B ratio of 3.71x
  • RMD may be overvalued based on its PEG ratio of 2.67x

You can access additional valuation analysis on RMD's stock here.

RMD Financial Health Summary

Positive Health Checks:

  • There are more short-term assets than short-term liabilities on the RMD balance sheet.
  • RMD profit margin has gone up from 15.2% to 21.5% in the past year.
  • There are more short-term assets than long-term liabilities on the RMD balance sheet.
  • RMD earnings of $1.03B is not sufficient to cover its interest payments.

Negative Health Checks:

  • RMD's operating cash flow of $370.22M allows it to safely service it's debt of $1.94B.
  • RMD has a relatively high debt to equity ratio of 0.79.
  • Total RMD debt is higher than 5 years ago, relative to shareholder equity.

Is it a good time to buy Resmed stock, according to analysts?

Out of 7 Wall Street analysts who track RMD, the consensus analyst rating on Resmed is a Strong Buy

Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.

Latest RMD Analyst Forecasts

David Low, a top 36% analyst from JP Morgan maintains RMD with a strong buy rating and raises their RMD price target from $245.00 to $260.00, on Jan 27, 2023.

Craig Wong-Pan, a top 31% analyst from RBC Capital maintains RMD with a hold rating and raises their RMD price target from $252.00 to $254.00, on Oct 28, 2022.

Matthew Mishan, a top 30% analyst from KeyBanc maintains RMD with a strong buy rating and raises their RMD price target from $276.00 to $280.00, on Oct 28, 2022.

Lyanne Harrison, a bottom 44% analyst from Bank of America upgrades RMD to a strong buy rating and raises their RMD price target from $245.00 to $260.00, on Oct 20, 2022.

Matthew Taylor, a top 17% analyst from Jefferies initiates coverage on RMD with a hold rating and announces their RMD price target of $245.00, on Oct 12, 2022.

You can dig deeper into what analysts are saying on the Resmed stock forecast page.

RMD Technical Indicators

SMA10
228.94
SMA20
224.13
SMA50
220.11
SMA100
220.39
SMA200
219.04
MACD
2.99
MACD Signal
3.33
MACD Histogram
-0.34
RSI
51.89
Stochastic %K
45.87
Stochastic %D
52.57
StochRSI %K
16.61
StochRSI %D
21.01

RMD Revenue

Last year, RMD earnings were $809.47M. During the last 5 year, RMD's earnings have gone up by 22.31% per year. This was faster than the Medical Instruments & Supplies industry average of 17.62%.

Last year, RMD revenue was $3.76B. In the last 5 year, RMD's revenue has grown by 11.38% per year. This was slower than the Medical Instruments & Supplies industry average of 15.61%.

Dig into RMD's earnings and revenue performance here.

Are RMD insiders buying or selling the stock?

Over the last year, insiders at RMD have sold more shares than they have bought.

Karen Drexler, Director of RMD, was the latest RMD insider to sell. They sold $134,588.52 worth of RMD stock on Feb 2, 2023.

Research more about who owns RMD stock here.

Does RMD stock generate passive income?

Resmed pays a dividend of 0.77%, compared to the Medical Instruments & Supplies industry's average dividend yield of 1%. If you owned $1,000 worth of RMD stock, you would have received $7.66 last year.

Resmed dividend payments have consistently grown over the past decade and have remained stable.

Dig into more analysis about Resmed dividend yield and history here.

What others are saying about RMD

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Execute your RMD buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly fine.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a particular price limit, use a limit order.

Press the Open Trade button and your broker will execute your order.

If you want more info about investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get updates on your RMD investment

Now that you own some RMD stock, you'll want to keep up with your new investment.

Start a watchlist to keep track of your RMD stock.

RMD Feed

How to Buy Stock in Resmed

To summarize, here are the 6 steps to buy stock in Resmed:

  1. Decide where to buy Resmed stock
  2. Open your brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Resmed stock
  5. Execute your RMD buy order
  6. Get updates on your RMD investment

If you are looking for a online brokerage, eToro is our favorite venue.

Get Started with eToro Today

If you would like to get the latest scoop on your investment in Resmed, click below.

NYSE: RMD
$224.60-2.01 (-0.89%)
Updated Feb 3, 2023
Open eToro Account
NYSE: RMD
$224.60-2.01 (-0.89%)
Updated Feb 3, 2023
Open eToro Account

FAQ

How much does it cost to buy one Resmed share?

As of Feb 3, 2023, it costs $224.60 to buy one share of Resmed stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.445 shares of RMD.

Get Started with eToro Today

Is now a good time to buy Resmed stock?

According to 7 Wall Street analysts who monitor Resmed, their consensus recommendation is to buy Resmed stock.

What is the best way to buy Resmed stock?

One way to place an order for Resmed stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.